ODwire.org has now uploaded Dr. Cooper’s Webinar on YouTube, also embedded in a discussion forum on the topic. It is of considerable length, but well worth your time to listen to the presentation and follow the slides.
Use of atropine for treating progression of myopia is rapidly gaining support in the ophthalmology community over the last year or two. Consider these sources:
- Topical Atropine in the Control of Myopia. Med Hypothesis Discov Innov Ophthalmol. 2016 Autumn; 5(3): 78–88.
4. How to Use Low-Dose Atropine to Slow Myopic Progression in Kids. American Academy of Ophthalmology – EyeNet Magazine.
5. Atropine effective for reducing myopic progression in children. One Network – American Academy of Ophthalmology.
6. Treatment for progressive myopia. AAPOS website.
As Drs. Farkas and Cooper note on ODwire.org, Optometry has a long history of interest in myopia control, and Dr. Cooper is on the advisory board of Myopia Management – a site dedicated specifically to this subject.
Naturally there are other approaches to curbing the progression of myopia beyond atropine and multifocal glasses, such as orthokeratology and multifocal soft lenses, which have garnered optometric attention. Dr. Gary Gerber, the principal brain behind Treehouse Eyes (for which Dr. Cooper is also an advisor) has wondered why more optometrists haven’t yet followed Dr. Cooper’s lead in the use of atropine for controlling myopia progression. I sense that our field may be at a tipping point in this discussion, and Dr. Cooper is actively advocating his approach through his OD.wire webinar, and the recent article in VDR.